Literature DB >> 28956322

Multiple Sclerosis: Unprecedented Progress But Significant Challenges Ahead.

Devon S Conway1, Le H Hua2, Jeffrey A Cohen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28956322      PMCID： PMC5722778          DOI： 10.1007/s13311-017-0576-1

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  16 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 2.  Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.

Authors:  Lilyana Amezcua; Flavia Nelson
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 3.  Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials.

Authors:  Maria Pia Sormani; Matteo Pardini
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 4.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 5.  Cladribine to Treat Relapsing Forms of Multiple Sclerosis.

Authors:  Gavin Giovannoni
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 6.  Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis.

Authors:  Harold L Atkins; Mark S Freedman
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 7.  Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA.

Authors:  Daniel M Hartung
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 8.  Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis.

Authors:  Burhan Z Chaudhry; Jeffrey A Cohen; Devon S Conway
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 9.  Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions.

Authors:  Andrew L Smith; Jeffrey A Cohen; Le H Hua
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 10.  Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding.

Authors:  Rhonda Voskuhl; Callene Momtazee
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.